18 December 1992
12 August 1988
COMMERCIAL ITEM DESCRIPTION
The General Services Administration has approved the use of this Commercial Item Description.
Shall be Bumetanide Tablets.
All ingredients shall be of pharmaceutical grade.
1. 0.5 mg
2. 1 mg.
3. 2 mg.
Each tablet shall contain the labeled amount of Bumetanide, within the applicable assay limits. When assayed by a suitable, accurate and reproducible method.
Each tablet shall be marked/embossed with a product identification code to identify the active ingredient(s), strength, and manufacturer. The materials used in marking/embossing the dosage forms shall be acceptable to the FDA. The actual code used for the product shall be left to the discretion of the supplier.
Workmanship. The tablets shall be free from defects which detract from its appearance or impair its serviceability.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business